Breast Cancer Treatment May Lead to Hip
FRIDAY, Feb. 4 (HealthDay News) -- Middle-aged breast cancer
survivors face an increased risk for hip fractures, a condition
normally uncommon in women younger than 70, a new study has
Researchers at Northwestern University in Chicago say that this
may be because early menopause caused by breast cancer treatment
and the effects of breast cancer drugs could weaken the bones by
the time women reach middle age.
The finding came from a study of six women who had survived
breast cancer and, in their early 50s, were being treated for hip
Most of the women did not have osteoporosis, but they did have
lower-than-normal bone mineral density (osteopenia). This suggests
that rapid changes in bone architecture caused by chemotherapy,
early menopause and adjuvant breast cancer therapy may not be
detected on a bone mineral density test, said Dr. Beatrice Edwards,
an associate professor of medicine and orthopedic surgery and
director of the bone health and osteoporosis program Northwestern
University's Feinberg School of Medicine, who led the research.
The women had been diagnosed with early-stage breast cancer, and
their treatments had included lumpectomy, radiation therapy and
chemotherapy with cytoxan and adriamycin for one to four years
before they broke a hip. All of the women were perimenopausal at
the time of the fracture.
In four of the women, their breast cancer had grown in response
to estrogen, and their cancer therapy had included aromatase
inhibitors to prevent their bodies from making estrogen. Recent
research has linked aromatase inhibitors with possible bone loss in
"Although the majority of women with breast cancer can expect to be fully cured from the disease, the prevention of cancer treatment-induced bone loss is important to consider in cancer survival," Edwards said in a university news release.
"More research needs to be done before treatment guidelines are changed, but greater awareness of the adverse effects of certain breast cancer drugs is needed," she added.
The study is in the February issue of
Clinical Cancer Research.
The American Academy of Orthopaedic Surgeons has more about
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.